260 related articles for article (PubMed ID: 19542621)
1. Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.
de la Monte SM; Tong M
J Alzheimers Dis; 2009; 17(4):817-25. PubMed ID: 19542621
[TBL] [Abstract][Full Text] [Related]
2. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.
Tong M; Neusner A; Longato L; Lawton M; Wands JR; de la Monte SM
J Alzheimers Dis; 2009; 17(4):827-44. PubMed ID: 20387270
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
Lester-Coll N; Rivera EJ; Soscia SJ; Doiron K; Wands JR; de la Monte SM
J Alzheimers Dis; 2006 Mar; 9(1):13-33. PubMed ID: 16627931
[TBL] [Abstract][Full Text] [Related]
4. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
Moroz N; Tong M; Longato L; Xu H; de la Monte SM
J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
[TBL] [Abstract][Full Text] [Related]
5. Chronic ethanol exposure causes mitochondrial dysfunction and oxidative stress in immature central nervous system neurons.
Chu J; Tong M; de la Monte SM
Acta Neuropathol; 2007 Jun; 113(6):659-73. PubMed ID: 17431646
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
7. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
Rivera EJ; Goldin A; Fulmer N; Tavares R; Wands JR; de la Monte SM
J Alzheimers Dis; 2005 Dec; 8(3):247-68. PubMed ID: 16340083
[TBL] [Abstract][Full Text] [Related]
8. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
de la Monte SM; Tong M; Schiano I; Didsbury J
J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
[TBL] [Abstract][Full Text] [Related]
9. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
de la Monte SM
Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.
de la Monte SM; Tong M; Lester-Coll N; Plater M; Wands JR
J Alzheimers Dis; 2006 Sep; 10(1):89-109. PubMed ID: 16988486
[TBL] [Abstract][Full Text] [Related]
11. Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.
Tong M; Dong M; de la Monte SM
J Alzheimers Dis; 2009; 16(3):585-99. PubMed ID: 19276553
[TBL] [Abstract][Full Text] [Related]
12. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
Butterfield DA
Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
[TBL] [Abstract][Full Text] [Related]
13. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM
J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215
[TBL] [Abstract][Full Text] [Related]
14. Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.
Tong M; Longato L; de la Monte SM
BMC Endocr Disord; 2010 Mar; 10():4. PubMed ID: 20302640
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of ceramide-mediated neurodegeneration.
Tong M; de la Monte SM
J Alzheimers Dis; 2009; 16(4):705-14. PubMed ID: 19387107
[TBL] [Abstract][Full Text] [Related]
16. Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.
de la Monte SM; Tong M; Lawton M; Longato L
Mol Neurodegener; 2009 Dec; 4():54. PubMed ID: 20034403
[TBL] [Abstract][Full Text] [Related]
17. Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model.
Cohen AC; Tong M; Wands JR; de la Monte SM
Alcohol Clin Exp Res; 2007 Sep; 31(9):1558-73. PubMed ID: 17645580
[TBL] [Abstract][Full Text] [Related]
18. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
19. Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.
de la Monte SM
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1954-60. PubMed ID: 25088942
[TBL] [Abstract][Full Text] [Related]
20. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
